Shenzhen Chipscreen Biosciences' high P/E ratio, resulting from a strong share price surge, may be concerning due to the anticipated EPS slump. The company's shrinking earnings outlook isn't impacting its high P/E as much as expected, potentially leading to future shareholder disappointment.
微芯生物股票讨论区
暂无评论